Page 27 - merged

Index

Thursady, 19 November

Session # Abstract Title

P1‐094 (WPAIC) Improving Coping Strategy of Fire Evacuation of the Patients in Psychiatric Ward

Hwei‐Wen Huang (Taiwan)

P1‐095 (WPAIC) Incidence and Risk Factors of Workplace Violence among Psychiatric Health Care Staffs in South Taiwan: A
Retrospective Analysis Study
Yu‐Chen Lin (Taiwan)

P1‐096 (WPAIC) The Study of Risk Factors for Falls among Hospitalized Mental Patients
Shu‐Fang Su (Taiwan)

P1‐097 (WPAIC) Impacts of Duration of Untreated Psychosis on Brain Activation in Patients with First‐Episode Schizophrenia
in Taiwan: A Near‐Infrared Spectroscopy Study
Po‐Han Chou (Taiwan)

P1‐098 (WPAIC) Adjunctive Low‐Dose Metformin in Clozapine‐Treated Patients with Schizophrenia and Metabolic
Abnormalities
Chun‐Hsin Chen (Taiwan)

P1‐099 (WPAIC) Functional Disability and Quality of Life in Patients with Schizophrenia
Yin‐Huang Liao (Taiwan)

P1‐100 (WPAIC) The Psychiatric Symptom is an Important Factor Affecting Psychomotor Ability in Patients with
Schizophrenia
Yi‐Chia Liu (Taiwan)

P1‐101 (WPAIC) Trajectory of Symptom Improvement and Monoamine Oxidase a Gene Polymorphism in Schizophrenia:
Analysis of Clinical Trial Data Using a Latent Growth Curve
Chen‐Lin Chang (Taiwan)

P1‐102 (WPAIC) The Effectiveness of Disease Management Group Therapy in Schizophrenia
Hsin‐Fei Chang (Taiwan)

P1‐103 (WPAIC) Prevalence of Antipsychotic Related Constipation Inpatients with Schizophrenia: A Retrospective Study
Ching‐Hong Tsai (Taiwan)

P1‐104 (WPAIC) Using the Chinese‐Version Negative Symptom Assessment‐4 in Schizophrenia Patients
Yung‐Chieh Yen (Taiwan)

P1‐105 (WPAIC) Prevalence of Metabolic Syndrome in Patients with Chronic Schizophrenia
A‐Sheu Chang (Taiwan)

P1‐106 (WPAIC) Functional Outcomes with Once‐Monthly Paliperidone Palmitate in Acute and in Non‐Acute Patients with
Schizophrenia Previously Unsuccessfully Treated with Oral Antipsychotics
Andreas Schreiner (Germany)

P1‐107 (WPAIC) Once Monthly Paliperidone Palmitate – Tolerability and Treatment Response in Recently Diagnosed Versus
Chronic Non‐Acute Schizophrenia Patients Switched from Previously Unsuccessful Treatment with Oral
Antipsychotics
Andreas Schreiner (Germany)

P1‐108 (WPAIC) Treatment Response, Safety and Tolerability of Paliperidone Palmitate in Exacerbated Schizophrenia
Patients Treated with Oral Risperidone Or Paliperidone Er Immediately Prior to Enrollment‐ Results from A
6‐Month Prospective Flexible‐Dose Study
Andreas Schreiner (Germany)

P1‐109 (WPAIC) Paliperidone Palmitate – Impact on Negative, Disorganized and Depressive Symptoms, Subjective Well‐
Being and Patient Satisfaction in Patients with Schizophrenia Previously Unsuccessfully Treated with Oral
Antipsychotics
Andreas Schreiner (Germany)

P1‐110 (WPAIC) Paliperidone Palmitate in Non‐Acute But Symptomatic Patients with Schizophrenia Previously
Unsuccessfully Treated with Oral Aripiprazole
Andreas Schreiner (Germany)

-6-